Somite.ai
AI-driven digital twin of embryo development for cell-based therapies.
About
Somite.ai is developing a computational model, a digital twin of the embryo, to simulate its development and behavior. This AI-powered approach aims to guide decision-making in the creation of human tissue for cell-based therapies, with the mission to transform the lives of millions. Teams look it up for Life Sciences, Digital Twin, Therapeutics.
Frequently asked
What does Somite.ai do?
Somite.ai is a Life Sciences company that offers Software. Teams look it up for Digital Twin, Therapeutics, Genetics. It is based in Tel Aviv, Israel and was founded in 2023. It was formerly known as Somite Therapeutics. Public records show about 84 people and $57M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Somite.ai raised?
Somite.ai has raised a total of $57M in funding. The most recent round on record is Series A.
Where is Somite.ai headquartered?
Somite.ai is headquartered in Tel Aviv, Israel.
When was Somite.ai founded?
Somite.ai was founded in 2023.
What industry does Somite.ai operate in?
Somite.ai operates in Life Sciences, Digital Twin, Therapeutics, Genetics, Biotech.
How many employees does Somite.ai have?
Somite.ai has approximately 84 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.